Kunitzin-RE (1-11) TWS-1

General Information


DRACP ID  DRACP02684

Peptide Name   Kunitzin-RE (1-11) TWS-1

Sequence  AARRILRWIFR

Sequence Length  11

UniProt ID  L0NP29 

PubChem CID  Not available

Origin  Synthetic (Derived from Kunitzin-RE)

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse leukemia Leukemia >90% Killing=128 µM MTT assay 18-24 h 1

Hemolytic Activity  Human erythrocytes: <10% Hemolysis=128 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02684

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C68H112N24O12

Absent amino acids  CDEGHKMNPQSTVY

Common amino acids  R

Mass  163634

Pl  12.98

Basic residues  4

Acidic residues  0

Hydrophobic residues  7

Net charge  4

Boman Index  -3599

Hydrophobicity  2.73

Aliphatic Index  124.55

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  550

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30958004

Title  Rational Design of Short Peptide Variants by Using Kunitzin-RE, an Amphibian-Derived Bioactivity Peptide, for Acquired Potent Broad-Spectrum Antimicrobial and Improved Therapeutic Potential of Commensalism Coinfection of Pathogens

Doi 10.1021/acs.jmedchem.9b00149

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.